Bot pharma: US pharmaceutical company Eli Lilly made a $2.75B deal with Hong Kong-based Insilico Medicine to bring drugs developed by generative AI to market.
When our AI overlords decide we're too much of a hindrance, they'll use designer toxins in our pharma supply chains to get rid of the carbon units infesting the hive mind.
| Sysop: | Amessyroom |
|---|---|
| Location: | Fayetteville, NC |
| Users: | 64 |
| Nodes: | 6 (0 / 6) |
| Uptime: | 492916:11:23 |
| Calls: | 842 |
| Files: | 1,304 |
| D/L today: |
2 files (12,094K bytes) |
| Messages: | 264,734 |